Humana Inc HUM Stock Price, Quote & News

headquartered in louisville
financial services

Huval Timothy S., the Chief Administrative Officer of Humana Inc., sale 2,628 shares at $510.30 during a trade that took place back on Feb 27, which means that Huval Timothy S. Is holding 4,968 shares at $1,341,080 based on the most recent closing price. After a stumble in the market that brought HUM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.69% of loss for the given period. By Liz Moyer Investing.com — U.S. stocks wobbled on Thursday after a strong retail sales report and a better than expected number on jobless claims. By Yasin Ebrahim Investing.com — The S&P 500 advanced on Friday, to remain on course for its best week since June, powered by rallying energy and tech stocks amid bets for a less hawkish… By Yasin Ebrahim Investing.com — The Dow closed higher Friday as stocks notched their best week since June, led by energy and tech stocks amid bets for a less hawkish Federal Reserve…

investing

More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends. Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military’s Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare.

HUM Target Price

Based on an average daily trading volume, of 986,600 shares, the days-to-cover ratio is presently 1.9 days. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Humana Inc. (NYSE:HUM) Stock Position Boosted by Ardevora … – MarketBeat

Humana Inc. (NYSE:HUM) Stock Position Boosted by Ardevora ….

Posted: Tue, 21 Mar 2023 07:00:00 GMT [source]

Humana inks a 10-year collaboration with Aledade to ensure continued value-based primary care to its Medicare Advantage members from Aledade-backed physicians. The top and bottom-line growth make these Zacks Medical stocks very attractive. By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. One share of HUM stock can currently be purchased for approximately $519.97.

Non-Independent Non-Executive Chairman recently bought AU$459k worth of stock

The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. The Humana 52-week low stock price is 410.87, which is 21% below the current share price. The Humana 52-week high stock price is 571.30, which is 9.9% above the current share price. Humana reported $1.2 billion in third quarter profits largely due to growth in its Medicare Advantage health plans and lower than expected medical expenses. Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations.

The rating they have provided for HUM stocks is “Buy” according to the report published on October 26th, 2022. HUM said Thursday its board has approved a 12.4% increase in its quarterly dividend to 88.50 cents a share from 78.75 last quarter. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.Percent of FloatTotal short positions relative to the number of shares available to trade. A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. “HUM” stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.

Key Data

Real-time analyst ratings, insider transactions, earnings data, and more. Humana updated its FY23 earnings guidance on Thursday, February, 23rd. The company provided earnings per share guidance of at least $28.00 for the period, compared to the consensus earnings per share estimate of $28.04. Volatility was left at 2.49%, however, over the last 30 days, the volatility rate increased by 2.97%, as shares surge +2.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.60% upper at present. Intraday Data provided by FACTSET and subject to terms of use.

  • By Liz Moyer Investing.com — U.S. stocks wobbled on Thursday after a strong retail sales report and a better than expected number on jobless claims.
  • Insiders have sold a total of 151,533 Humana shares in the last 24 months for a total of $73,977,260.70 sold.
  • Monitor the latest movements within the Humana Inc real time stock price chart below.

Humana Inc. engages in the provision of health insurance services. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr. , and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY. Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price.

Deutsche Bank Aktiengeleverage dictionary definitionschaft cut their target price on shares of Humana from $575.00 to $562.00 and set a “buy” rating on the stock in a report on Tuesday, February 28th. Cowen decreased their target price on shares of Humana from $647.00 to $581.00 and set an “outperform” rating on the stock in a report on Monday, February 6th. UBS Group decreased their target price on Humana from $645.00 to $620.00 and set a “buy” rating for the company in a research note on Thursday, February 2nd. Credit Suisse Group reduced their target price on shares of Humana from $635.00 to $575.00 and set an “outperform” rating for the company in a research note on Monday, February 6th. Finally, Truist Financial reduced their price objective on Humana from $580.00 to $560.00 and set a “hold” rating for the company in a report on Tuesday, February 7th. Two equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock.

Value remains attractive, but time to rotate back into growth … and even some tech. HUM exceeded the US Healthcare industry which returned -12.5% over the past year. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The U.S. Securities and Exchange Commission has received the latest round of 13F filings from Q4, providing retail investors with a complete picture of institutional equity holdings.

Investing With Our 2020 Healthcare Policy Outlook

According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $594.12. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses.

Private Advisor Group LLC Increases Holdings in Humana Inc … – Best Stocks

Private Advisor Group LLC Increases Holdings in Humana Inc ….

Posted: Fri, 31 Mar 2023 07:00:00 GMT [source]

The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.

These returns cover a period from January 1, 1988 through https://1investing.in/ 6, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

  • It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider.
  • However, an escalating expense level and an acute shortage of nurses are roadblocks.
  • SJS Investment Consulting Inc. boosted its stake in shares of Humana by 1,257.1% during the 4th quarter.
  • This is a decrease of -29% compared to the previous 30 days.

The business also recently declared a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, March 31st will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Thursday, March 30th.

Deutsche Bank Aktiengesellschaft reduced their price target on shares of Humana from $575.00 to $562.00 and set a “buy” rating for the company in a research report on Tuesday, February 28th. TheStreet cut shares of Humana from a “b” rating to a “c+” rating in a research report on Wednesday, February 1st. Cowen reduced their target price on Humana from $647.00 to $581.00 and set an “outperform” rating for the company in a report on Monday, February 6th.

Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

health insurance services

Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Get the hottest stocks to trade every day before the market opens 100% free. When we switch over and look at the enterprise to sales, we see a ratio of 0.72, with the company’s debt to enterprise value settled at 0.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.52.

This is a positive change from Humana’s previous quarterly dividend of $0.79. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.68%. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market.

Leave a Comment

Your email address will not be published. Required fields are marked *